Nelson Barton
Verenium Corporation
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nelson Barton.
Applied and Environmental Microbiology | 2004
James B. Garrett; Keith Kretz; Eileen O'donoghue; Janne Kerovuo; William Kim; Nelson Barton; Geoffrey P. Hazlewood; Jay M. Short; Dan E. Robertson; Kevin A. Gray
ABSTRACT The inclusion of phytase in monogastric animal feed has the benefit of hydrolyzing indigestible plant phytate (myo-inositol 1,2,3,4,5,6-hexakis dihydrogen phosphate) to provide poultry and swine with dietary phosphorus. An ideal phytase supplement should have a high temperature tolerance, allowing it to survive the feed pelleting process, a high specific activity at low pHs, and adequate gastric performance. For this study, the performance of a bacterial phytase was optimized by the use of gene site saturation mutagenesis technology. Beginning with the appA gene from Escherichia coli, a library of clones incorporating all 19 possible amino acid changes and 32 possible codon variations in 431 residues of the sequence was generated and screened for mutants exhibiting improved thermal tolerance. Fourteen single site variants were discovered that retained as much as 10 times the residual activity of the wild-type enzyme after a heated incubation regimen. The addition of eight individual mutations into a single construct (Phy9X) resulted in a protein of maximal fitness, i.e., a highly active phytase with no loss of activity after heating at 62°C for 1 h and 27% of its initial activity after 10 min at 85°C, which was a significant improvement over the appA parental phytase. Phy9X also showed a 3.5-fold enhancement in gastric stability.
Journal of Industrial Microbiology & Biotechnology | 2015
Nelson Barton; Anthony P. Burgard; Jason S. Crater; Robin E. Osterhout; Priti Pharkya; Brian Steer; Jun Sun; John D. Trawick; Stephen J. Van Dien; Tae Hoon Yang; Harry Yim
Genomatica has established an integrated computational/experimental metabolic engineering platform to design, create, and optimize novel high performance organisms and bioprocesses. Here we present our platform and its use to develop E. coli strains for production of the industrial chemical 1,4-butanediol (BDO) from sugars. A series of examples are given to demonstrate how a rational approach to strain engineering, including carefully designed diagnostic experiments, provided critical insights about pathway bottlenecks, byproducts, expression balancing, and commercial robustness, leading to a superior BDO production strain and process.
Archive | 2003
Svetlana Gramatikova; Geoff Hazlewood; David E. Lam; Nelson Barton
Archive | 2004
Walter Callen; Toby Richardson; Gerhard Frey; Kevin A. Gray; Janne S. Kerovuo; Malgorzata Slupska; Nelson Barton; Eileen O'donoghue; Carl Miller
Archive | 2009
Christopher L. G. Dayton; Nelson Barton; Analia Bueno; Joslin G. Cuenca; Tim Hitchman; Katie A. Kline; Jonathan Lyon; Mark L. Miller; Mark A. Wall
Archive | 2001
Jay M. Short; Keith Kretz; Kevin A. Gray; Nelson Barton; James B. Garrett; Eileen O'donoghue; Eric J. Mathur
Archive | 2003
Michelle Cayouette; Connie Jo Hansen; Amy Mcclure; May Sun; Svetlana Gramatikova; Mark Dycaico; Nelson Barton; Justin T. Stege; Nahla Aboushadi
Archive | 2001
Jay M. Short; Eric J. Mathur; W. Michael Lafferty; Nelson Barton; Kevin Chow
Archive | 2010
Christopher L. G. Dayton; Flavio da Silva Galhardo; Nelson Barton; Tim Hitchman; Jonathan Lyon; Eileen O'donoghue; Mark A. Wall
Archive | 2005
Nelson Barton; Eileen O'donoghue; Gerhard Frey